A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable InfantsNota de prensa19 febrero, 2026 · 08:00 | PR News
Japón aprueba los fortificantes de Prolacta Bioscience, elaborados 100% con leche maternaNota de prensa19 febrero, 2026 · 08:00 | PR News
Ashoka WhiteOak Emerging Markets Trust Plc - Monthly Update - January 2026Nota de prensa19 febrero, 2026 · 08:00 | PR News